Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
News & Comment
Drug-resistant bacteria have been on the offensive for years, with few new compounds available for a counterattack. But at a recent meeting, pharmaceutical companies introduced a promising crop of new antibiotics, with a variety of ways to beat back resistance. Whether companies have enough incentives to develop the most effective anti-resistance strategies--narrow-spectrum antibiotics--remains an open question. See sidebar
(p. 725).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science. ISSN 0036-8075 (print), 1095-9203 (online)